| dc.contributor.author | Alvarez-Gonzalez, C | en_US |
| dc.contributor.author | Adams, A | en_US |
| dc.contributor.author | Mathews, J | en_US |
| dc.contributor.author | Turner, BP | en_US |
| dc.contributor.author | Giovannoni, G | en_US |
| dc.contributor.author | Baker, D | en_US |
| dc.contributor.author | Schmierer, K | en_US |
| dc.date.accessioned | 2017-05-23T08:18:35Z | |
| dc.date.available | 2017-03-17 | en_US |
| dc.date.issued | 2017-07 | en_US |
| dc.date.submitted | 2017-05-19T23:37:51.461Z | |
| dc.identifier.issn | 2328-9503 | en_US |
| dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23283 | |
| dc.format.extent | 506 - 511 | en_US |
| dc.language.iso | en | en_US |
| dc.relation.ispartof | ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY | en_US |
| dc.rights | This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. | |
| dc.title | Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis | en_US |
| dc.type | Article | |
| dc.rights.holder | © 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. | |
| dc.identifier.doi | 10.1002/acn3.410 | en_US |
| pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000407601800005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
| pubs.issue | 7 | en_US |
| pubs.notes | No embargo | en_US |
| pubs.publication-status | Published | en_US |
| pubs.volume | 4 | en_US |
